nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—Quinapril—Ramipril—type 1 diabetes mellitus	0.452	0.512	CrCrCtD
Fentanyl—Benazepril—Ramipril—type 1 diabetes mellitus	0.43	0.488	CrCrCtD
Fentanyl—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.00274	0.028	CcSEcCtD
Fentanyl—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.0027	0.0276	CcSEcCtD
Fentanyl—Balance disorder—Ramipril—type 1 diabetes mellitus	0.00242	0.0247	CcSEcCtD
Fentanyl—Parosmia—Ramipril—type 1 diabetes mellitus	0.00204	0.0208	CcSEcCtD
Fentanyl—Burning sensation—Ramipril—type 1 diabetes mellitus	0.0019	0.0195	CcSEcCtD
Fentanyl—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.00177	0.0181	CcSEcCtD
Fentanyl—Ageusia—Ramipril—type 1 diabetes mellitus	0.00163	0.0167	CcSEcCtD
Fentanyl—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.0016	0.0163	CcSEcCtD
Fentanyl—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00153	0.0156	CcSEcCtD
Fentanyl—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00151	0.0154	CcSEcCtD
Fentanyl—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00149	0.0152	CcSEcCtD
Fentanyl—Cough increased—Ramipril—type 1 diabetes mellitus	0.00145	0.0148	CcSEcCtD
Fentanyl—Glossitis—Ramipril—type 1 diabetes mellitus	0.00144	0.0147	CcSEcCtD
Fentanyl—Drug interaction—Ramipril—type 1 diabetes mellitus	0.00143	0.0146	CcSEcCtD
Fentanyl—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00124	0.0127	CcSEcCtD
Fentanyl—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.0012	0.0123	CcSEcCtD
Fentanyl—Urine output increased—Ramipril—type 1 diabetes mellitus	0.0012	0.0122	CcSEcCtD
Fentanyl—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00111	0.0113	CcSEcCtD
Fentanyl—Polyuria—Ramipril—type 1 diabetes mellitus	0.00109	0.0112	CcSEcCtD
Fentanyl—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00108	0.0111	CcSEcCtD
Fentanyl—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00105	0.0108	CcSEcCtD
Fentanyl—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00104	0.0106	CcSEcCtD
Fentanyl—Amnesia—Ramipril—type 1 diabetes mellitus	0.00102	0.0104	CcSEcCtD
Fentanyl—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00102	0.0104	CcSEcCtD
Fentanyl—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00101	0.0103	CcSEcCtD
Fentanyl—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.000993	0.0101	CcSEcCtD
Fentanyl—Arthritis—Ramipril—type 1 diabetes mellitus	0.000988	0.0101	CcSEcCtD
Fentanyl—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.000984	0.0101	CcSEcCtD
Fentanyl—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.000965	0.00985	CcSEcCtD
Fentanyl—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.000953	0.00973	CcSEcCtD
Fentanyl—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000877	0.00896	CcSEcCtD
Fentanyl—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.000877	0.00896	CcSEcCtD
Fentanyl—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000868	0.00887	CcSEcCtD
Fentanyl—Gastritis—Ramipril—type 1 diabetes mellitus	0.00085	0.00868	CcSEcCtD
Fentanyl—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00083	0.00848	CcSEcCtD
Fentanyl—Influenza—Ramipril—type 1 diabetes mellitus	0.00083	0.00848	CcSEcCtD
Fentanyl—Asthma—Ramipril—type 1 diabetes mellitus	0.00083	0.00848	CcSEcCtD
Fentanyl—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.000817	0.00834	CcSEcCtD
Fentanyl—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.000809	0.00826	CcSEcCtD
Fentanyl—Sweating increased—Ramipril—type 1 diabetes mellitus	0.000809	0.00826	CcSEcCtD
Fentanyl—Benzphetamine—SLC18A2—type 1 diabetes mellitus	0.000804	0.132	CrCbGaD
Fentanyl—Bronchitis—Ramipril—type 1 diabetes mellitus	0.000799	0.00816	CcSEcCtD
Fentanyl—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.000796	0.00813	CcSEcCtD
Fentanyl—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.000789	0.00805	CcSEcCtD
Fentanyl—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000776	0.00793	CcSEcCtD
Fentanyl—Mepenzolate—CHRM2—type 1 diabetes mellitus	0.000774	0.127	CrCbGaD
Fentanyl—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.000772	0.00788	CcSEcCtD
Fentanyl—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000765	0.00781	CcSEcCtD
Fentanyl—Weight increased—Ramipril—type 1 diabetes mellitus	0.000756	0.00772	CcSEcCtD
Fentanyl—Quinapril—ACE—type 1 diabetes mellitus	0.000747	0.123	CrCbGaD
Fentanyl—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000734	0.0075	CcSEcCtD
Fentanyl—Renal failure—Ramipril—type 1 diabetes mellitus	0.000728	0.00743	CcSEcCtD
Fentanyl—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000726	0.00741	CcSEcCtD
Fentanyl—Jaundice—Ramipril—type 1 diabetes mellitus	0.000722	0.00737	CcSEcCtD
Fentanyl—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000722	0.00737	CcSEcCtD
Fentanyl—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00072	0.00735	CcSEcCtD
Fentanyl—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00072	0.00735	CcSEcCtD
Fentanyl—Sweating—Ramipril—type 1 diabetes mellitus	0.00071	0.00725	CcSEcCtD
Fentanyl—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.0007	0.00715	CcSEcCtD
Fentanyl—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000698	0.00713	CcSEcCtD
Fentanyl—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000695	0.00709	CcSEcCtD
Fentanyl—Diphenidol—CHRM2—type 1 diabetes mellitus	0.000678	0.111	CrCbGaD
Fentanyl—Darifenacin—CHRM2—type 1 diabetes mellitus	0.000672	0.111	CrCbGaD
Fentanyl—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000655	0.00669	CcSEcCtD
Fentanyl—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000653	0.00667	CcSEcCtD
Fentanyl—Benazepril—ACE—type 1 diabetes mellitus	0.00065	0.107	CrCbGaD
Fentanyl—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00064	0.00654	CcSEcCtD
Fentanyl—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000628	0.00642	CcSEcCtD
Fentanyl—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00062	0.00633	CcSEcCtD
Fentanyl—Flushing—Ramipril—type 1 diabetes mellitus	0.000617	0.0063	CcSEcCtD
Fentanyl—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0006	0.00613	CcSEcCtD
Fentanyl—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000599	0.00612	CcSEcCtD
Fentanyl—Benzatropine—CHRM2—type 1 diabetes mellitus	0.000597	0.0981	CrCbGaD
Fentanyl—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000594	0.00606	CcSEcCtD
Fentanyl—Alopecia—Ramipril—type 1 diabetes mellitus	0.000587	0.006	CcSEcCtD
Fentanyl—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000582	0.00595	CcSEcCtD
Fentanyl—Erythema—Ramipril—type 1 diabetes mellitus	0.000579	0.00591	CcSEcCtD
Fentanyl—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000579	0.00591	CcSEcCtD
Fentanyl—Tension—Ramipril—type 1 diabetes mellitus	0.000568	0.0058	CcSEcCtD
Fentanyl—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000567	0.00579	CcSEcCtD
Fentanyl—Nervousness—Ramipril—type 1 diabetes mellitus	0.000562	0.00574	CcSEcCtD
Fentanyl—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000556	0.00568	CcSEcCtD
Fentanyl—Tremor—Ramipril—type 1 diabetes mellitus	0.000542	0.00554	CcSEcCtD
Fentanyl—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000537	0.00548	CcSEcCtD
Fentanyl—Agitation—Ramipril—type 1 diabetes mellitus	0.000532	0.00543	CcSEcCtD
Fentanyl—Malaise—Ramipril—type 1 diabetes mellitus	0.000522	0.00533	CcSEcCtD
Fentanyl—Vertigo—Ramipril—type 1 diabetes mellitus	0.00052	0.00531	CcSEcCtD
Fentanyl—Syncope—Ramipril—type 1 diabetes mellitus	0.000519	0.0053	CcSEcCtD
Fentanyl—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000518	0.00529	CcSEcCtD
Fentanyl—Palpitations—Ramipril—type 1 diabetes mellitus	0.000511	0.00522	CcSEcCtD
Fentanyl—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000508	0.00519	CcSEcCtD
Fentanyl—Cough—Ramipril—type 1 diabetes mellitus	0.000505	0.00516	CcSEcCtD
Fentanyl—Convulsion—Ramipril—type 1 diabetes mellitus	0.000501	0.00512	CcSEcCtD
Fentanyl—Chest pain—Ramipril—type 1 diabetes mellitus	0.000493	0.00503	CcSEcCtD
Fentanyl—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000493	0.00503	CcSEcCtD
Fentanyl—Myalgia—Ramipril—type 1 diabetes mellitus	0.000493	0.00503	CcSEcCtD
Fentanyl—Anxiety—Ramipril—type 1 diabetes mellitus	0.000491	0.00501	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000489	0.005	CcSEcCtD
Fentanyl—Discomfort—Ramipril—type 1 diabetes mellitus	0.000487	0.00497	CcSEcCtD
Fentanyl—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000482	0.00492	CcSEcCtD
Fentanyl—Confusional state—Ramipril—type 1 diabetes mellitus	0.000476	0.00486	CcSEcCtD
Fentanyl—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000472	0.00482	CcSEcCtD
Fentanyl—Oedema—Ramipril—type 1 diabetes mellitus	0.000472	0.00482	CcSEcCtD
Fentanyl—Shock—Ramipril—type 1 diabetes mellitus	0.000465	0.00474	CcSEcCtD
Fentanyl—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000463	0.00473	CcSEcCtD
Fentanyl—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000462	0.00472	CcSEcCtD
Fentanyl—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000461	0.00471	CcSEcCtD
Fentanyl—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000459	0.00468	CcSEcCtD
Fentanyl—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000456	0.00466	CcSEcCtD
Fentanyl—Anorexia—Ramipril—type 1 diabetes mellitus	0.00045	0.0046	CcSEcCtD
Fentanyl—Propafenone—ADRB1—type 1 diabetes mellitus	0.000449	0.0739	CrCbGaD
Fentanyl—Hypotension—Ramipril—type 1 diabetes mellitus	0.000441	0.00451	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00043	0.00439	CcSEcCtD
Fentanyl—Insomnia—Ramipril—type 1 diabetes mellitus	0.000427	0.00436	CcSEcCtD
Fentanyl—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000424	0.00433	CcSEcCtD
Fentanyl—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000421	0.0043	CcSEcCtD
Fentanyl—Somnolence—Ramipril—type 1 diabetes mellitus	0.00042	0.00429	CcSEcCtD
Fentanyl—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000416	0.00425	CcSEcCtD
Fentanyl—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00041	0.00419	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000408	0.00416	CcSEcCtD
Fentanyl—Fatigue—Ramipril—type 1 diabetes mellitus	0.000407	0.00416	CcSEcCtD
Fentanyl—Alfentanil—ALB—type 1 diabetes mellitus	0.000404	0.0664	CrCbGaD
Fentanyl—Constipation—Ramipril—type 1 diabetes mellitus	0.000404	0.00412	CcSEcCtD
Fentanyl—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000389	0.00397	CcSEcCtD
Fentanyl—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000386	0.00394	CcSEcCtD
Fentanyl—Urticaria—Ramipril—type 1 diabetes mellitus	0.000375	0.00383	CcSEcCtD
Fentanyl—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000373	0.00381	CcSEcCtD
Fentanyl—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000373	0.00381	CcSEcCtD
Fentanyl—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000348	0.00355	CcSEcCtD
Fentanyl—Asthenia—Ramipril—type 1 diabetes mellitus	0.000339	0.00346	CcSEcCtD
Fentanyl—Pruritus—Ramipril—type 1 diabetes mellitus	0.000334	0.00341	CcSEcCtD
Fentanyl—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000323	0.0033	CcSEcCtD
Fentanyl—Dizziness—Ramipril—type 1 diabetes mellitus	0.000312	0.00319	CcSEcCtD
Fentanyl—Diphenhydramine—CHRM2—type 1 diabetes mellitus	0.000307	0.0505	CrCbGaD
Fentanyl—Vomiting—Ramipril—type 1 diabetes mellitus	0.0003	0.00307	CcSEcCtD
Fentanyl—Rash—Ramipril—type 1 diabetes mellitus	0.000298	0.00304	CcSEcCtD
Fentanyl—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000297	0.00304	CcSEcCtD
Fentanyl—Headache—Ramipril—type 1 diabetes mellitus	0.000296	0.00302	CcSEcCtD
Fentanyl—Nausea—Ramipril—type 1 diabetes mellitus	0.00028	0.00286	CcSEcCtD
Fentanyl—OPRK1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	2.79e-05	0.00205	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	2.76e-05	0.00204	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	2.76e-05	0.00203	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	2.69e-05	0.00198	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	2.68e-05	0.00197	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	2.64e-05	0.00194	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	2.62e-05	0.00193	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	2.62e-05	0.00193	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	2.59e-05	0.00191	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	2.59e-05	0.00191	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	2.51e-05	0.00185	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—IL6—type 1 diabetes mellitus	2.48e-05	0.00182	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	2.47e-05	0.00182	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	2.44e-05	0.00179	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	2.43e-05	0.00179	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—SST—type 1 diabetes mellitus	2.42e-05	0.00178	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	2.42e-05	0.00178	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	2.42e-05	0.00178	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	2.41e-05	0.00178	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GAL—type 1 diabetes mellitus	2.38e-05	0.00175	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	2.35e-05	0.00173	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	2.35e-05	0.00173	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	2.35e-05	0.00173	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HBA2—type 1 diabetes mellitus	2.22e-05	0.00163	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	2.21e-05	0.00163	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	2.2e-05	0.00162	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—SST—type 1 diabetes mellitus	2.2e-05	0.00162	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	2.2e-05	0.00162	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	2.2e-05	0.00162	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	2.19e-05	0.00162	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	2.19e-05	0.00161	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	2.19e-05	0.00161	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	2.18e-05	0.0016	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	2.16e-05	0.00159	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—SST—type 1 diabetes mellitus	2.13e-05	0.00157	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	2.12e-05	0.00156	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	2.11e-05	0.00155	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—G6PC2—type 1 diabetes mellitus	2.09e-05	0.00154	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	2.08e-05	0.00153	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	2.05e-05	0.00151	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	2.05e-05	0.00151	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	2.02e-05	0.00149	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	2.01e-05	0.00148	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	2.01e-05	0.00148	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	1.99e-05	0.00146	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.96e-05	0.00144	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—SST—type 1 diabetes mellitus	1.93e-05	0.00142	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	1.93e-05	0.00142	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	1.92e-05	0.00142	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GAL—type 1 diabetes mellitus	1.9e-05	0.0014	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	1.9e-05	0.00139	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.89e-05	0.00139	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.88e-05	0.00138	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.88e-05	0.00138	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	1.86e-05	0.00137	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.83e-05	0.00135	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.83e-05	0.00135	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.82e-05	0.00134	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ABCC8—type 1 diabetes mellitus	1.81e-05	0.00133	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—SST—type 1 diabetes mellitus	1.8e-05	0.00132	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	1.79e-05	0.00132	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.77e-05	0.0013	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.77e-05	0.0013	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.76e-05	0.0013	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.72e-05	0.00127	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GAL—type 1 diabetes mellitus	1.66e-05	0.00123	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.66e-05	0.00122	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.65e-05	0.00121	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.65e-05	0.00121	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	1.63e-05	0.0012	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	1.63e-05	0.0012	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	1.62e-05	0.0012	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	1.61e-05	0.00119	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.61e-05	0.00118	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HBA2—type 1 diabetes mellitus	1.6e-05	0.00118	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.6e-05	0.00118	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	1.6e-05	0.00118	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	1.6e-05	0.00118	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.58e-05	0.00117	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.56e-05	0.00115	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.55e-05	0.00114	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.54e-05	0.00113	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.54e-05	0.00113	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—G6PC2—type 1 diabetes mellitus	1.51e-05	0.00111	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.5e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.49e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.49e-05	0.0011	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	1.48e-05	0.00109	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.48e-05	0.00109	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.48e-05	0.00109	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	1.47e-05	0.00108	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.45e-05	0.00107	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—KCNJ11—type 1 diabetes mellitus	1.43e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.42e-05	0.00104	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	1.41e-05	0.00104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	1.41e-05	0.00104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.4e-05	0.00103	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.4e-05	0.00103	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.39e-05	0.00102	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.39e-05	0.00102	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.39e-05	0.00102	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.37e-05	0.00101	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.36e-05	0.001	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.36e-05	0.000998	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.35e-05	0.000994	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	1.31e-05	0.000963	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.31e-05	0.000963	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.31e-05	0.000962	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SST—type 1 diabetes mellitus	1.3e-05	0.000957	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.3e-05	0.000956	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.3e-05	0.000956	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.29e-05	0.000953	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.24e-05	0.000916	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.23e-05	0.000903	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	1.21e-05	0.000891	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ITPR3—type 1 diabetes mellitus	1.21e-05	0.000889	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.17e-05	0.000864	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.16e-05	0.000853	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.16e-05	0.000852	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.14e-05	0.00084	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SST—type 1 diabetes mellitus	1.14e-05	0.00084	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	1.14e-05	0.000838	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HBA1—type 1 diabetes mellitus	1.14e-05	0.000836	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.14e-05	0.000836	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOC3—type 1 diabetes mellitus	1.13e-05	0.000831	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.12e-05	0.000821	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTT1—type 1 diabetes mellitus	1.11e-05	0.000816	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.1e-05	0.000813	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.1e-05	0.000808	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.1e-05	0.000808	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	1.08e-05	0.000798	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.08e-05	0.000798	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.08e-05	0.000796	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.05e-05	0.000774	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.04e-05	0.000763	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	1.03e-05	0.000761	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.02e-05	0.000748	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	9.87e-06	0.000727	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.85e-06	0.000725	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.81e-06	0.000722	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.79e-06	0.00072	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SST—type 1 diabetes mellitus	9.64e-06	0.00071	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.6e-06	0.000706	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.5e-06	0.0007	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.48e-06	0.000698	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	9.45e-06	0.000696	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.03e-06	0.000665	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.97e-06	0.00066	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GCG—type 1 diabetes mellitus	8.84e-06	0.000651	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	8.73e-06	0.000642	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.64e-06	0.000636	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.61e-06	0.000633	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	8.59e-06	0.000632	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.52e-06	0.000627	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.38e-06	0.000617	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CD86—type 1 diabetes mellitus	8.29e-06	0.00061	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	8.28e-06	0.00061	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.27e-06	0.000609	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.26e-06	0.000608	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	8.21e-06	0.000605	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.2e-06	0.000603	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	8.16e-06	0.000601	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.03e-06	0.000591	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	8.02e-06	0.00059	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.01e-06	0.00059	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.92e-06	0.000583	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	7.89e-06	0.000581	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.86e-06	0.000579	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	7.8e-06	0.000574	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CAT—type 1 diabetes mellitus	7.48e-06	0.000551	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.47e-06	0.00055	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	7.46e-06	0.000549	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.35e-06	0.000541	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.3e-06	0.000537	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.27e-06	0.000535	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.24e-06	0.000533	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.19e-06	0.000529	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	7.01e-06	0.000516	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	7e-06	0.000516	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	6.89e-06	0.000508	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.69e-06	0.000492	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.65e-06	0.000489	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	6.59e-06	0.000485	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—INS—type 1 diabetes mellitus	6.51e-06	0.00048	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	6.39e-06	0.00047	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.32e-06	0.000465	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.3e-06	0.000464	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.27e-06	0.000462	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.21e-06	0.000457	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	6.2e-06	0.000456	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	6.16e-06	0.000453	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.12e-06	0.000451	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	6.08e-06	0.000448	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.08e-06	0.000447	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	6.05e-06	0.000445	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	6.05e-06	0.000445	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.82e-06	0.000428	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.71e-06	0.000421	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	5.71e-06	0.00042	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.53e-06	0.000407	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.5e-06	0.000405	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	5.41e-06	0.000398	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.3e-06	0.00039	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.11e-06	0.000376	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.1e-06	0.000376	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.01e-06	0.000369	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—INS—type 1 diabetes mellitus	4.97e-06	0.000366	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.85e-06	0.000357	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.84e-06	0.000356	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	4.83e-06	0.000355	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	4.82e-06	0.000355	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.82e-06	0.000355	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	4.81e-06	0.000354	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.67e-06	0.000344	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.65e-06	0.000342	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	4.55e-06	0.000335	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	4.35e-06	0.000321	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.31e-06	0.000318	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.25e-06	0.000313	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.25e-06	0.000313	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.23e-06	0.000312	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.23e-06	0.000311	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	4.08e-06	0.0003	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.08e-06	0.0003	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.06e-06	0.000299	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	3.82e-06	0.000281	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	3.8e-06	0.000279	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	3.73e-06	0.000274	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.7e-06	0.000273	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.59e-06	0.000265	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	3.59e-06	0.000264	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.59e-06	0.000264	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.57e-06	0.000263	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.57e-06	0.000263	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	3.29e-06	0.000242	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.25e-06	0.000239	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	3.15e-06	0.000232	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.02e-06	0.000222	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	2.97e-06	0.000219	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.85e-06	0.00021	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.74e-06	0.000202	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—INS—type 1 diabetes mellitus	2.71e-06	0.000199	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.51e-06	0.000185	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.5e-06	0.000184	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.48e-06	0.000183	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.38e-06	0.000175	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.11e-06	0.000155	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.67e-06	0.000123	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.53e-06	0.000113	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.46e-06	0.000108	CbGpPWpGaD
